Kolexia
Simon Nicolas Pharmacien
Simon Nicolas
Pharmacien
Centre Hospitalier de Lille
Lille, France
81 Activités
304 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Complications postopératoires Tumeurs du cerveau Arthralgie Tumeurs de l'ovaire Tumeurs colorectales Tumeurs du poumon Gliome Maladie du greffon contre l'hôte

Collaborateurs

Voir plus
Odou Pascal
Odou Pascal
Centre Hospitalier de Lille, Lille, France
Decaudin Bertrand
Decaudin Bertrand
Centre Hospitalier de Lille, Lille, France
Vasseur Michele
Vasseur Michele
Centre Hospitalier de Lille, Lille, France
Lannoy Damien
Lannoy Damien
Centre Hospitalier de Lille, Lille, France

Industries

Voir plus
Novartis
2 collaboration(s)
Dernière en 2021
Jazz Pharmaceuticals
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
A second round of anti-CD19 CAR T-cell therapy in diffuse large B-cell lymphoma: when persistence pays off.
Leukemia & lymphoma   05 mars 2024
Combination of a propofol emulsion with alpha-2 adrenergic receptor agonists used for multimodal analgesia or sedation in intensive care units: a physicochemical stability study.
European journal of hospital pharmacy : science and practice   30 janvier 2024
Therapeutic Drug Monitoring and Pharmacogenetic Testing as Guides to Psychotropic Drug Dose Adjustment: An Observational Study.
Pharmaceuticals (Basel, Switzerland)   22 décembre 2023
Evaluation of cancer drug infusion devices prior to the implementation of a compounding robot.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners   18 mai 2023
Cistracurium Besylate 10 mg/mL Solution Compounded in a Hospital Pharmacy to Prevent Drug Shortages: A Stability Study Involving Four Degradation Products.
Pharmaceutics   04 mai 2023
The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients.
Blood advances   08 mars 2023
Perception, knowledge, practices and training regarding the risk of exposure to antineoplastic drugs in three French compounding units.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners   14 février 2023
Four-year follow-up of surface contamination by antineoplastic drugs in a compounding unit.
Occupational and environmental medicine   30 janvier 2023
Knowledge and practices about safe handling regarding the risk of exposure to antineoplastic drugs for caregivers in compounding units and in operating rooms performing HIPEC/PIPAC.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners   13 décembre 2022
Treatment options for drug-induced sialorrhea: Prescribing guidelines.
L'Encephale   18 août 2022